- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Robert Gabbay on Eliminating "Old-Fashioned" Finger Stick Rule
Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association (ADA), talks about the "old-fashioned" finger stick requirement for continuous glucose monitoring.
Transcript
Can you discuss ADA’s advocacy efforts on behalf of patients to eliminate the finger stick requirement for continuous glucose monitoring and the response you are getting from patients?
We're so pleased that the American Diabetes Association has been able to lead the way in reducing the barriers to access to continuous glucose monitors (CGM). One of the recent wins has been eliminating the, I would say frankly, old-fashioned rule that one had to document 4-times-a-day testing by finger stick before someone will be eligible for a continuous glucose monitor. What we already know from our own patients is that, many times, CGM is the helpful tool because they're not checking their blood glucose is as often as they could. I could tell you in my practice, where I continue to see patients at the Joslin Diabetes Center, this has just really opened the door to more individuals having access to this technology that is clearly beneficial for people with diabetes.
Top 5 Most-Read Articles About Automated Insulin Delivery in 2022
December 20th 2022Content published on AJMC.com focusing on automated insulin delivery devices over the past year highlighted utilization of these devices by age, compared different types of systems, looked at barriers to uptake, and examined equity issues standing in the way of access.
Read More
Primary Care Clinicians Can Embrace CGM Implementation With Support, Study Finds
December 6th 2022Patients with diabetes may benefit from continuous glucose monitoring (CGM) as a standard of care in the primary care setting, according to a recent study that assessed clinicians’ attitudes toward prescribing these tools.
Read More
Do Automated Insulin Delivery Systems Have a Place in T2D Treatment?
November 18th 2022Although automated insulin delivery systems have gained traction in type 1 diabetes, further research is needed to determine the feasibility of using such systems for patients with type 2 diabetes.
Read More
